Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROTAVAC 5D Efficacy in Chilean Infants
NCT06200844Phase 3Active, not recruiting
- Sponsor
- Bharat Biotech
- Start
- Jul 2023
- Primary completion
- Jan 2025
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine (live attenuated, oral) in rotavirus infection, sponsored by Bharat Biotech. Started Jul 2023; status: active, not recruiting.
02
Drugs
rotavirus vaccine (live attenuated, oral)
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT06200844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200844.